17-Jul-2026
PRNewswire (Tue, 14-Jul 8:05 AM ET)
Avantor to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026
PRNewswire (Wed, 1-Jul 8:05 AM ET)
Avantor Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
PRNewswire (Tue, 19-May 6:05 AM ET)
Avantor’s Q1 2026 Delivers Resilient Sales Amid Lower Margins as Bioscience & Medtech Stabilize
Market Chameleon (Wed, 29-Apr 3:06 AM ET)
Avantor Reports First Quarter 2026 Results
PRNewswire (Wed, 29-Apr 6:05 AM ET)
PRNewswire (Thu, 23-Apr 5:05 PM ET)
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
Globe Newswire (Wed, 22-Apr 9:32 AM ET)
PRNewswire (Tue, 21-Apr 8:05 AM ET)
Avantor’s 2025 Results Highlight Strategic Revival Amid Margin Pressure and Cash Flow Strength
Market Chameleon (Wed, 11-Feb 2:07 AM ET)
Avantor’s Q3 2025: Strategic Actions Spotlighted Amid Sales Pressure and $500 Million Share Buyback
Market Chameleon (Wed, 29-Oct 3:05 AM ET)
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Avantor trades on the NYSE stock market under the symbol AVTR.
As of July 17, 2026, AVTR stock price declined to $11.07 with 9,966,378 million shares trading.
AVTR has a beta of 1.76, meaning it tends to be more sensitive to market movements. AVTR has a correlation of 0.14 to the broad based SPY ETF.
AVTR has a market cap of $7.56 billion. This is considered a Mid Cap stock.
Last quarter Avantor reported $2 billion in Revenue and $.17 earnings per share. This beat revenue expectation by $37 million and exceeded earnings estimates by $.01.
In the last 3 years, AVTR traded as high as $28.00 and as low as $7.27.
The top ETF exchange traded funds that AVTR belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.
AVTR has underperformed the market in the last year with a return of -16.7%, while SPY returned +19.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in AVTR shares. However, AVTR has outperformed the market in the last 3 month and 2 week periods, returning +29.9% and +7.3%, while SPY returned +4.9% and -0.2%, respectively. This indicates AVTR has been having a stronger performance recently.
AVTR support price is $10.92 and resistance is $11.60 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVTR shares will trade within this expected range on the day.